UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection

Gastroenterology (New York, N.Y. 1943), 2019-01, Vol.156 (2), p.325-337

2019

Volltextzugriff (PDF)

The role of innate immunity in the immunopathology and treatment of HBV infection

Journal of hepatology, 2016-04, Vol.64 (1), p.S60-S70

2016

Volltextzugriff (PDF)

Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver

PLoS pathogens, 2014-06, Vol.10 (6), p.e1004210

2014

Volltextzugriff (PDF)

New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies

Baillière's best practice & research. Clinical gastroenterology, 2017-06, Vol.31 (3), p.337-345

Gehring, Adam J.

2017

Volltextzugriff (PDF)

The immune response during hepatitis B virus infection

Journal of general virology, 2006-06, Vol.87 (6), p.1439-1449

2006

Volltextzugriff (PDF)

Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection

Frontiers in immunology, 2021-09, Vol.12, p.648420-648420

2021

Volltextzugriff (PDF)

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

Nature communications, 2022-11, Vol.13 (1), p.6992-6992, Article 6992

2022

Volltextzugriff (PDF)

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

Proceedings of the National Academy of Sciences - PNAS, 2023-06, Vol.120 (24), p.e2220294120-e2220294120

2023

Volltextzugriff (PDF)

S-pecial delivery: Implications of HBV surface antigen subviral particles carrying microRNA payloads

Hepatology (Baltimore, Md.), 2024-07

Gehring, Adam J.

2024

Volltextzugriff (PDF)

Mobilizing monocytes to cross-present circulating viral antigen in chronic infection

The Journal of clinical investigation, 2013-09, Vol.123 (9), p.3766-3776

2013

Volltextzugriff (PDF)

Mechanisms of HBV immune evasion

Antiviral research, 2020-07, Vol.179, p.104816-104816, Article 104816

2020

Volltextzugriff (PDF)

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B

Journal of hepatology, 2010-03, Vol.52 (3), p.330-339

2010

Volltextzugriff (PDF)

Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections

Antiviral research, 2024-06, Vol.226, p.105893-105893, Article 105893

2024

Volltextzugriff (PDF)

Modulation of the CD8+-T-Cell Response by CD4+ CD25+ Regulatory T Cells in Patients with Hepatitis B Virus Infection

Journal of Virology, 2005-03, Vol.79 (6), p.3322-3328

2005

Volltextzugriff (PDF)

The Human Male Liver Is Predisposed to Inflammation Via Enhanced Myeloid Responses to Inflammatory Triggers

Frontiers in immunology, 2022-04, Vol.13, p.818612-818612

2022

Volltextzugriff (PDF)

Engineering T Cells Specific for a Dominant Severe Acute Respiratory Syndrome Coronavirus CD8 T Cell Epitope

Journal of Virology, 2011-10, Vol.85 (20), p.10464-10471

2011

Volltextzugriff (PDF)

Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire

Journal of Virology, 2008-11, Vol.82 (22), p.10986-10997

2008

Volltextzugriff (PDF)

A Practical Approach to Immunotherapy of Hepatocellular Carcinoma Using T Cells Redirected Against Hepatitis B Virus

Molecular therapy. Nucleic acids, 2013, Vol.2 (8), p.e114-e114, Article e114

2013

Volltextzugriff (PDF)

Using Immunomodulatory and Antiviral Strategies in the Quest to Cure Hepatitis B Virus Infection

Gastroenterology & hepatology, 2022-03, Vol.18 (3), p.162-165

Gehring, Adam J

2022

Volltextzugriff (PDF)

Targeting Hepatitis B Virus-Infected Cells with a T-Cell Receptor-Like Antibody

Journal of Virology, 2011-03, Vol.85 (5), p.1935-1942

2011

Volltextzugriff (PDF)

IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells

The Journal of immunology (1950), 2013-04, Vol.190 (7), p.3142-3152

2013

Volltextzugriff (PDF)

Intrahepatic T cells with NK-like properties: Expanding the repertoire of lymphocytes sensitive to bystander activation

Journal of hepatology, 2022-10, Vol.77 (4), p.915-917

2022

Volltextzugriff (PDF)

The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2

Infection and Immunity, 2003-08, Vol.71 (8), p.4487-4497

2003

Volltextzugriff (PDF)

Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient

Journal of hepatology, 2015-02, Vol.62 (2), p.486-491

2015

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

ThemaHepatitis B

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(48)
Humans
(43)
Gastroenterology & Hepatology
(17)
Immunology
(16)
Animals
(13)
Hepatitis B Virus
(13)
Hepatitis B Virus - Immunology
(13)
Biological And Medical Sciences
(12)
Microbiology
(11)
Virology
(11)
Cd8-Positive T-Lymphocytes - Immunology
(10)
Hepatitis B, Chronic - Immunology
(10)
Male
(9)
Female
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Mice
(8)
Adult
(7)
Cell Line
(7)
Cells, Cultured
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection

The role of innate immunity in the immunopathology and treatment of HBV infection

Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver

New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies

The immune response during hepatitis B virus infection

Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity

Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus

S-pecial delivery: Implications of HBV surface antigen subviral particles carrying microRNA payloads

Mobilizing monocytes to cross-present circulating viral antigen in chronic infection

Mechanisms of HBV immune evasion

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B

Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections

Modulation of the CD8+-T-Cell Response by CD4+ CD25+ Regulatory T Cells in Patients with Hepatitis B Virus Infection

The Human Male Liver Is Predisposed to Inflammation Via Enhanced Myeloid Responses to Inflammatory Triggers

Engineering T Cells Specific for a Dominant Severe Acute Respiratory Syndrome Coronavirus CD8 T Cell Epitope

Host Ethnicity and Virus Genotype Shape the Hepatitis B Virus-Specific T-Cell Repertoire

A Practical Approach to Immunotherapy of Hepatocellular Carcinoma Using T Cells Redirected Against Hepatitis B Virus

Using Immunomodulatory and Antiviral Strategies in the Quest to Cure Hepatitis B Virus Infection

Targeting Hepatitis B Virus-Infected Cells with a T-Cell Receptor-Like Antibody

IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells

Intrahepatic T cells with NK-like properties: Expanding the repertoire of lymphocytes sensitive to bystander activation

The Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient

Aktive Filter

Suchergebnisse filtern